Z-1921-2016Class II
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection...
Remel Inc / initiated 2016-03-24 / Terminated
Remel Inc began a recall of Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in... on . FDA classified it as Class II and gives the reason as "Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1921-2016
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Remel Inc
- Product
- Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic
- Product code
- JTT Susceptibility Test Powders, Antimicrobial
- Reason for recall
- Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.
- FDA root cause
- Under Investigation by firm
- Action
- Customers were notified by letter beginning on March 24, 2016.
- Quantity in commerce
- 2 units were imported and distributed domestically
- Distribution
- US distribution in MO.
- Product codes and lots
- Lot 1717357 Exp: 31Aug2017
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1921-2016 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
